HFYFX | VIHAX | HFYFX / VIHAX | |
Total Expense Ratio | 0.76 | 0.17 | 447% |
Annual Report Gross Expense Ratio | 0.76 | 0.17 | 447% |
Fund Existence | 8 years | 9 years | - |
Gain YTD | 21.566 | 17.828 | 121% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.31B | 11B | 21% |
Annual Yield % from dividends | 2.59 | 4.14 | 63% |
Returns for 1 year | 19.08 | 13.72 | 139% |
Returns for 3 years | 33.92 | 25.45 | 133% |
Returns for 5 years | 69.49 | 54.53 | 127% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTIX | 28.77 | N/A | N/A |
Fidelity Advisor Biotechnology I | |||
FEYIX | 27.80 | N/A | N/A |
Fidelity Advisor Asset Manager 85% I | |||
MNHCX | 25.60 | N/A | N/A |
Manning & Napier Pro-Blend Max Term L | |||
EEMEX | 8.73 | N/A | N/A |
MFS Emerging Markets Equity Research R2 | |||
TEOOX | 9.27 | N/A | N/A |
Transamerica Emerging Markets Eq R6 |